This information is not medical advice and is not a substitute for diagnosis or treatment by a physician.Data sources and disclaimers (data limitations, copyright, etc.)The analysis on "Effects of bebtelovimab injection: A Synthesis of Findings from 14 Studies" on this page is based on PubMed data provided by the U.S. National Library of Medicine (NLM). However, NLM does not endorse or verify these analyses.

This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.

This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Effects of bebtelovimab injection: A Synthesis of Findings from 14 Studies", please consult your doctor.

For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to Dataset
Please check the disclaimer.
This page's analysis is based on PubMed data provided by the U.S. National Library of Medicine (NLM).
Original Abstract of the Article

Major Research Findings

Multiple studies have shown that beta-blockers are effective in lowering intraocular pressure. 4 , 12 , 9 These medications can also affect the entire body, such as the heart and lungs. 4 , 7 , 1 Research has shown that systemic effects vary depending on the type of beta-blocker. For example, timolol, a non-selective beta-blocker, may be more likely to cause depression than betaxolol, a selective beta-blocker. 2 On the other hand, betaxolol has a high selectivity for the heart, making it a safer option than timolol for patients with heart disease. 7 , 5 , 12 , 9 Betaxolol has also been shown to be relatively safe for patients with respiratory diseases such as asthma. 1 , 6 Beta-blockers can cause exercise-induced hypoglycemia, and this effect is thought to be more pronounced with non-selective beta-blockers than with selective beta-blockers. 7

Benefits and Risks

Benefit Summary

Multiple studies have shown that it can be expected to have a lowering effect on intraocular pressure. 4 , 12 , 9 Betaxolol has a high selectivity for the heart, making it a safer option than timolol for patients with heart disease. 7 , 5 , 12 , 9 Betaxolol has also been shown to be relatively safe for patients with respiratory diseases such as asthma. 1 , 6

Risk Summary

Systemic effects are a concern. It can affect the heart and lungs, and may cause depression. 4 , 7 , 2 It can also cause exercise-induced hypoglycemia. 7

Comparison of Studies

Commonalities of Studies

Multiple studies have shown that beta-blockers are effective in lowering intraocular pressure. 4 , 12 , 9 These medications can also affect the entire body, such as the heart and lungs. 4 , 7 , 1

Differences in Studies

Studies vary in the type of beta-blocker used, the dosage, and the evaluation methods. Therefore, it is difficult to directly compare the results of each study. However, some studies have shown that the systemic effects vary depending on the type of beta-blocker. For example, timolol, a non-selective beta-blocker, may be more likely to cause depression than betaxolol, a selective beta-blocker. 2

Consistency and Contradictions of Results

Multiple studies have shown that beta-blockers are effective in lowering intraocular pressure. 4 , 12 , 9 On the other hand, the results vary regarding systemic effects. For example, betaxolol has a high selectivity for the heart, making it a safer option than timolol for patients with heart disease. 7 , 5 , 12 , 9 However, other studies have concluded that betaxolol is safe for patients with respiratory diseases. 1 , 6 Thus, there may be contradictions in the results, and further research is needed.

Points to Note Regarding Application to Daily Life

Beta-blockers are effective medications for lowering intraocular pressure, but systemic effects need to be considered. Patients with underlying conditions such as heart disease, respiratory disease, and diabetes should be cautious when using beta-blockers. If you are considering using beta-blockers, be sure to consult with your doctor.

Limitations of Current Research

This research is based on a limited number of papers and does not cover all papers. Each paper has different subjects, study designs, and evaluation methods, making it difficult to directly compare the results. Therefore, the results of this study should only be considered as a reference, and further research is needed.

Future Research Directions

Further research is needed to better understand the systemic effects of beta-blockers. In particular, more research is needed on the long-term effects and the effects on patients with specific diseases. The development of alternative medications for beta-blockers is also expected.

Conclusion

Beta-blockers are effective medications for lowering intraocular pressure, but systemic effects need to be considered. Patients with underlying conditions such as heart disease, respiratory disease, and diabetes should be cautious when using beta-blockers. If you are considering using beta-blockers, be sure to consult with your doctor. Furthermore, further research is needed to better understand the systemic effects of beta-blockers.


Literature analysis of 14 papers
Positive Content
13
Neutral Content
0
Negative Content
1
Article Type
14
0
0
0
14

Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : German


Language : French


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.